KTTA: Pasithea Therapeutics Company Short-Term Debt
Pasithea Therapeutics (KTTA) develops small molecules to combat severe psychiatric and brain disorders, diversifying risks across various CNS targeting methods. The business model relies on the search for neurofibromatosis treatments and the launch of ketamine therapy centers. The asset's price trajectory reflects the current stage of liquidity burn for clinical trials, with the indicator standing at 0.00.
Metric breakdowns and analytics for Pasithea Therapeutics Corp (KTTA)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Pasithea Therapeutics|KTTA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Pasithea|KTTA - Company Total Debt Obligations|Debt to Book Value Pasithea Therapeutics Corp.|KTTA - Amount of Long-Term Liabilities|Company Short-Term Debts Pasithea Therapeutics|Quick Ratio pasitheaclinics.com
- earnings and multiples data:
Fundamental company analysis:pasitheaclinics.com - KTTA
This indicator measures the aggregate of liabilities with a maturity of up to one year, reflecting the issuer's ability to promptly service debt without incurring critical interest expenses. By analyzing the current volume of short-term liabilities, an investor can assess the financial flexibility of Pasithea Therapeutics (KTTA), which is critical for maintaining the academic environment and retaining rare neuroscience specialists through a stock option system.
Who Pasithea Therapeutics competes with
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Short-Term Debt ACADIA Pharmaceuticals|xenon-pharma.com - Current Liabilities|Company Short-Term Debts VKTX|Company Short-Term Debts Supernus Pharmaceuticals, Inc. (SUPN)|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|Short-Term Debt Volume Denali Corp (DNLI)|Harmony Biosciences - Company Short-Term Debts|Short-Term Debt Volume biohavenpharma.com BHVN|AMLX (Amylyx Pharmaceuticals, Inc.) - Company Current Liabilities|TRVI: Amount of Current Liabilities|PRAX (Praxis Medicines) - Company Short-Term Debts|AVXL: Company Short-Term Loans and Borrowings|Company Short-Term Debts CBLL|PRTA - Short-Term Debt|Company Short-Term Debts ALEC (Alector)|Company Short-Term Debts Annexon Biosciences ANNX|OMER: Company Current Liabilities|Company Short-Term Loans and Borrowings NGNE (Neurogene Therapeutics)|ACIU (AC Immune) - Company Current Liabilities|VYGR: Amount of Current Liabilities|NMRA (Neumora Therapeutics, Inc.) - Company Short-Term Debts|SCLX: Company Short-Term Loans and Borrowings|Company Short-Term Debts TVGN|ACOG - Short-Term Debt|Company Short-Term Debt Cognition Therapeutics, Inc. CGTX|Company Short-Term Loans and Borrowings IKT|Cassava Sciences - Company Short-Term Debts|ASRT - Company Short-Term Debts|coyatherapeutics.com (COYA) - Company Short-Term Debt|Current Liabilities VTGN (Vistagen)|OVID (Ovid Therapeutics Inc) - Company Short-Term Debts|Short-Term Debt acumenpharm.com ABOS|Company Current Liabilities CRVO (CervoMed)|Company Short-Term Debts alteritytherapeutics.com (ATHE)|Clene - Company Current Liabilities|Amount of Current Liabilities PEPG (PepGen Inc)|Jupiter Neurosciences - Company Short-Term Debts|Short-Term Debt Volume relmada.com RLMD|ANVS: Company Short-Term Debts|Company Current Liabilities Grace Therapeutics|Company Short-Term Debt Firefly Neuroscience Inc|ANEW Medical, Inc. (KLTO) - Short-Term Debt Volume|Company Short-Term Debt NeuroSense Therapeutics (NRSN)|Company Short-Term Debts revivapharma.com (RVPH)|MetaVia - Company Current Liabilities|Amount of Current Liabilities NRXS (NeurAxis Inc.)|HSDT: Company Current Liabilities|Passage Bio, Inc. - Amount of Current Liabilities|NEUP: Company Short-Term Debts|minervaneurosciences.com (NERV) - Company Short-Term Debts|Company Short-Term Debt Athira Pharma|Company Short-Term Indebtedness ADXN (Addex Therapeutics Ltd.)|Company Short-Term Debts ALZN|CYCN - Short-Term Debt|Protagenic Therapeutics, Inc. - Company Current Liabilities|Company Short-Term Debts Cortigent Inc CRGT|ATXI - Company Short-Term Debt|Company Short-Term Loans and Borrowings BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Company Short-Term Debt|Short-Term Debt Chromocell (CHRO)|Company Short-Term Debt Eliem Therapeutics, Inc.|Intra-Cellular - Current Liabilities|Company Short-Term Debts LBPH|Company Short-Term Debts Marinus Pharmaceuticals Inc (MRNS)|Company Short-Term Debt NKGen NKGN|Short-Term Debt Volume NeuroBo Pharma (NRBO)|Sage Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume synaptogen.com SNPX|TRVN (Trevena) - Company Current Liabilities|VIGL: Amount of Current Liabilities|WENA (Anew Medical, Inc.) - Company Short-Term Debts|CERE: Company Short-Term Loans and Borrowings